Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VACUVOL: Paradoxical MEF Fall After Bronchodilation
NCT03062904Unknown
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Feb 2014
- Primary completion
- Dec 2019
- Modality
- Implantable Devices, Transdermal Patches, Inhalation Devices
- Countries
- 1
01
Overview
Open-label, single-arm trial of Combivent in asthma, sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Occurrence or increase of the Expiratory Flow Limitation (EFL) up to 2 hours. Status: unknown.
02
Drugs
Combivent
03
Conditions
asthma
Beyond the preview
Go deeper on NCT03062904.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03062904.